U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C30H40N4.2Cl
Molecular Weight 527.571
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEQUALINIUM CHLORIDE

SMILES

[Cl-].[Cl-].CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C

InChI

InChIKey=LTNZEXKYNRNOGT-UHFFFAOYSA-N
InChI=1S/C30H38N4.2ClH/c1-23-21-27(31)25-15-9-11-17-29(25)33(23)19-13-7-5-3-4-6-8-14-20-34-24(2)22-28(32)26-16-10-12-18-30(26)34;;/h9-12,15-18,21-22,31-32H,3-8,13-14,19-20H2,1-2H3;2*1H

HIDE SMILES / InChI

Molecular Formula C30H38N4
Molecular Weight 454.6495
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: http://adisinsight.springer.com/drugs/800041300 | http://www.netdoctor.co.uk/medicines/mouth-and-teeth/a6534/dequadin-lozenges-dequalinium/ | https://en.wikipedia.org/wiki/Dequalinium

Dequalinium is a quaternary ammonium cation commonly available as the dichloride salt. Dequalinium chloride has an antiseptic effect against a wide range of bacteria, yeasts, and some fungi and viruses. It kills the micro-organisms associated with various mild infections of the mouth and throat. Also, Dequalinium chloride is active against the bacteria which cause bacterial vaginosis. Dequalinium Chloride (DECA) is a PKC inhibitor and high-affinity blocker CNGA1 channel, and nearly as effective on heteromeric CNGA1+CNGB1 channels. Common side effects are: vaginal discharge; vaginal itching or vaginal burning; vaginal yeast infection (thrush); tender tongue.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P29973
Gene ID: 1259.0
Gene Symbol: CNGA1
Target Organism: Homo sapiens (Human)
Target ID: heteromeric CNGA1+CNGB1 channels
11.5 µM [Ki]
14.0 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Fluomizin

Approved Use

Dequalinium chloride has an antiseptic effect against a wide range of bacteria, yeasts, and some fungi and viruses. Dequalinium chloride is active against the bacteria which cause bacterial vaginosis.
Curative
Dequadin lozenges

Approved Use

Dequalinium chloride has an antiseptic effect against a wide range of bacteria, yeasts, and some fungi and viruses. It kills the micro-organisms associated with various mild infections of the mouth and throat.
Curative
Dequadin lozenges

Approved Use

Anginova is used for the local treatment of acute inflammatory diseases in the mouth and throat area such as sore throat, difficulty swallowing, thrush, aphthous ulcers, etc. and as an adjuvant medication for angina.
Curative
Dequadin lozenges

Approved Use

Anginova is used for the local treatment of acute inflammatory diseases in the mouth and throat area such as sore throat, difficulty swallowing, thrush, aphthous ulcers, etc. and as an adjuvant medication for angina
PubMed

PubMed

TitleDatePubMed
The pharmacology of hSK1 Ca2+-activated K+ channels expressed in mammalian cell lines.
2000 Feb
Block of rat brain recombinant SK channels by tricyclic antidepressants and related compounds.
2000 Jul 28
Pharmacological characterization of small-conductance Ca(2+)-activated K(+) channels stably expressed in HEK 293 cells.
2000 Mar
Towards mitochondrial gene therapy: DQAsomes as a strategy.
2001
DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria.
2001 Aug 10
Suramin prevents cerebellar granule cell-death induced by dequalinium.
2001 Feb
Mitochondrial DNA metabolism targeting drugs.
2001 Jul 2
Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems.
2001 Jul 2
Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells.
2001 Jul 2
Structure and design of polymeric surfactant-based drug delivery systems.
2001 Jun 15
Pharmacological characterisation of the human small conductance calcium-activated potassium channel hSK3 reveals sensitivity to tricyclic antidepressants and antipsychotic phenothiazines.
2001 May
Occupational allergic contact dermatitis from alkylammonium amidobenzoate.
2001 May-Jun
The noradrenergic inhibition of an apamin-sensitive, small-conductance Ca2+-activated K+ channel in hypothalamic gamma-aminobutyric acid neurons: pharmacology, estrogen sensitivity, and relevance to the control of the reproductive axis.
2001 Oct
Determination for micro amounts of nucleic acids by a resonance light scattering technique with dequalinium chloride.
2001 Oct 31
Characterisation of [(125)I]-apamin binding sites in rat brain membranes with HE293 cells transfected with SK channel subtypes.
2001 Sep
Expression and activity of potassium ion channels in human prostate cancer.
2002 Dec 1
Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by dipyrone.
2002 May 24
Modulation of small conductance calcium-activated potassium (SK) channels: a new challenge in medicinal chemistry.
2003 Apr
Gelsolin suppresses tumorigenicity through inhibiting PKC activation in a human lung cancer cell line, PC10.
2003 Feb 24
Dequalinium: a novel, high-affinity blocker of CNGA1 channels.
2003 Jan
Cloning and expression of a small-conductance Ca(2+)-activated K+ channel from the mouse cochlea: coexpression with alpha9/alpha10 acetylcholine receptors.
2004 Apr
Crystal structures of QacR-diamidine complexes reveal additional multidrug-binding modes and a novel mechanism of drug charge neutralization.
2004 Apr 2
Additive antinociceptive effect of the combination of diazoxide, an activator of ATP-sensitive K+ channels, and sodium nitroprusside and dibutyryl-cGMP.
2004 Apr 5
The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-beta on melanosomes.
2004 Jul 15
Effects of the antitumoural dequalinium on NB4 and K562 human leukemia cell lines. Mitochondrial implication in cell death.
2005 Oct
[Treatment of urogenital infections in lower part of the genital organs in pregnant women which are at risk of miscarriage].
2006 Apr-May
Inhibition of protein kinase C by dequalinium analogues: structure-activity studies on head group variations.
2006 Dec 1
Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC).
2007 Feb
Dequalinium induces cell death in human leukemia cells by early mitochondrial alterations which enhance ROS production.
2007 Jul
Involvement of chloride channel coupled GABA(C) receptors in the peripheral antinociceptive effect induced by GABA(C) receptor agonist cis-4-aminocrotonic acid.
2007 Mar 13
Synthesis, antifungal and haemolytic activity of a series of bis(pyridinium)alkanes.
2007 May 15
G-Protein Inwardly Rectifying Potassium Channel 1 (GIRK1) Knockdown Decreases Beta-Adrenergic, MAP Kinase and Akt Signaling in the MDA-MB-453 Breast Cancer Cell Line.
2008
[Diagnosis and treatment of infectious pharyngeal inflammation].
2008
ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.
2008
Dequalinium-induced cell death of yeast expressing alpha-synuclein-GFP fusion protein.
2008 Jul
Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by the alpha(2)-adrenoceptor agonist xylazine.
2009 Dec
Dequalinium, a new inhibitor of Mycobacterium tuberculosis mycothiol ligase identified by high-throughput screening.
2009 Jul
Effect of dequalinium on the oxidative stress in Plasmodium berghei-infected erythrocytes.
2009 Jun
New method for the quantification of dequalinium cations in pharmaceutical samples by absorption and fluorescence diode array thin-layer chromatography.
2009 Jun 19
Real-time analysis of amyloid fibril formation of alpha-synuclein using a fibrillation-state-specific fluorescent probe of JC-1.
2009 Mar 1
Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay.
2009 Sep 14
Alpha-tocopherol transfer protein disruption confers resistance to malarial infection in mice.
2010 Apr 19
[The treatment of MRSA colonized middle ear; case report and literature review].
2010 Jul
Cell-based and cytokine-directed chemical screen to identify potential anti-multiple myeloma agents.
2010 Jul
Re-engineering the mitochondrial genomes in mammalian cells.
2010 Jun
Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis.
2010 Nov 15
Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens.
2010 Sep
Metabolic oxidative stress elicited by the copper(II) complex [Cu(isaepy)2] triggers apoptosis in SH-SY5Y cells through the induction of the AMP-activated protein kinase/p38MAPK/p53 signalling axis: evidence for a combined use with 3-bromopyruvate in neuroblastoma treatment.
2011 Aug 1
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.
2011 Jul 14
Patents

Sample Use Guides

1 vaginal tablet (10 mg) daily for 6 days
Route of Administration: Other
In Vitro Use Guide
multidrug-resistant lines were less sensitive than parental cell lines to the intrinsic growth inhibitory effects of dequalinium (IC50, 4.4 versus 0.3 microM in multidrug-resistant and sensitive P388 cells, respectively).
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:35:16 GMT 2025
Edited
by admin
on Mon Mar 31 17:35:16 GMT 2025
Record UNII
XYS8INN1I6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FLUOMIZIN
Preferred Name English
DEQUALINIUM CHLORIDE
EP   INCI   INN   JAN   MART.   MI   WHO-DD  
INCI   INN  
Official Name English
DEQUALINIUM CHLORIDE [MI]
Common Name English
DEQUALINIUM CHLORIDE [MART.]
Common Name English
DEKAMIN
Common Name English
GNF-PF-5483
Code English
1,1'-(1,10-DECANEDIYL)BIS-(4-AMINO-2-METHYLQUINOLINIUM CHLORIDE)
Common Name English
DEQUALINIUM CHLORIDE [EP MONOGRAPH]
Common Name English
NSC-166454
Code English
Dequalinium chloride [WHO-DD]
Common Name English
BAQD-10
Code English
BAQD 10
Code English
DECAMINE
Common Name English
DEQUALINIUM DICHLORIDE
Common Name English
1,10-DECAMETHYLENE-BIS(4-AMINOQUINALDINIUM CHLORIDE)
Common Name English
dequalinium chloride [INN]
Common Name English
1,1'-DECAMETHYLENEBIS(4-AMINOQUINALDINIUM CHLORIDE)
Common Name English
DEQUALINIUM CHLORIDE [JAN]
Common Name English
NORDMAN
Brand Name English
Classification Tree Code System Code
NCI_THESAURUS C795
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
Code System Code Type Description
NSC
166454
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY
INN
746
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY
PUBCHEM
10649
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY
ChEMBL
CHEMBL333826
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY
CHEBI
31466
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY
CAS
522-51-0
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY
SMS_ID
100000091069
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY
EVMPD
SUB06985MIG
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY
DRUG BANK
DBSALT001926
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY
MERCK INDEX
m4184
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID3045144
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY
FDA UNII
XYS8INN1I6
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY
RXCUI
3120
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY RxNorm
NCI_THESAURUS
C77046
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY
ECHA (EC/EINECS)
208-330-9
Created by admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY